PT  - JOURNAL ARTICLE
AU  - Lewis, Erika M
AU  - Mao, Lingchao
AU  - Wang, Lujia
AU  - Swanson, Kristin R
AU  - Barajas, Ramon F
AU  - Li, Jing
AU  - Tran, Nhan L
AU  - Hu, Leland S
AU  - Plaisier, Christopher L
TI  - Revealing the biology behind MRI signatures in high grade glioma
AID  - 10.1101/2023.12.08.23299733
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.12.08.23299733
4099  - http://medrxiv.org/content/early/2023/12/15/2023.12.08.23299733.short
4100  - http://medrxiv.org/content/early/2023/12/15/2023.12.08.23299733.full
AB  - Magnetic resonance imaging (MRI) measurements are routinely collected during the treatment of high-grade gliomas (HGGs) to characterize tumor boundaries and guide surgical tumor resection. Using spatially matched MRI and transcriptomics we discovered HGG tumor biology captured by MRI measurements. We strategically overlaid the spatially matched omics characterizations onto a pre-existing transcriptional map of glioblastoma multiforme (GBM) to enhance the robustness of our analyses. We discovered that T1+C measurements, designed to capture vasculature and blood brain barrier (BBB) breakdown and subsequent contrast extravasation, also indirectly reveal immune cell infiltration. The disruption of the vasculature and BBB within the tumor creates a permissive infiltrative environment that enables the transmigration of anti-inflammatory macrophages into tumors. These relationships were validated through histology and enrichment of genes associated with immune cell transmigration and proliferation. Additionally, T2-weighted (T2W) and mean diffusivity (MD) measurements were associated with angiogenesis and validated using histology and enrichment of genes involved in neovascularization. Furthermore, we establish an unbiased approach for identifying additional linkages between MRI measurements and tumor biology in future studies, particularly with the integration of novel MRI techniques. Lastly, we illustrated how noninvasive MRI can be used to map HGG biology spatially across a tumor, and this provides a platform to develop diagnostics, prognostics, or treatment efficacy biomarkers to improve patient outcomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by NIH-NINDS Award # 1R01NS123038-01, and 1R01NS119650-01.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Patient recruitment took place at both Barrow Neurological Institute (BNI) and Mayo Clinic in Arizona (MCA) through IRB approved protocols at each institution. Informed consent was obtained prior to enrollment. All datasets analyzed in the current study, including whole exome sequencing and RNA sequencing, are publicly accessible, with the Synapse (https://www.synapse.org/#!Synapse:syn52256644). The publicly available bulk RNA-seq data for TCGA-GBM were obtained from the UCSC Xena browser [https://gdc-hub.s3.us-east-1.amazonaws.com/download/TCGA-GBM.htseq_counts.tsv.gz]. The input data for the imaging analysis can be found at https://github.com/HuLiLab/Multi-Regional-GBM-Imaging-and-Genetics Source data are provided.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors. https://www.synapse.org/#!Synapse:syn52256644 https://gdc-hub.s3.us-east-1.amazonaws.com/download/TCGA-GBM.htseq_counts.tsv.gz https://github.com/HuLiLab/Multi-Regional-GBM-Imaging-and-Genetics